149 related articles for article (PubMed ID: 37678101)
1. Utilizing speech analysis to differentiate progressive supranuclear palsy from Parkinson's disease.
Kang K; Nunes AS; Sharma M; Hall AJ; Mishra RK; Casado J; Cole R; Derhammer M; Barchard G; Najafi B; Vaziri A; Wills AM; Pantelyat A
Parkinsonism Relat Disord; 2023 Oct; 115():105835. PubMed ID: 37678101
[TBL] [Abstract][Full Text] [Related]
2. Remote at-home wearable-based gait assessments in Progressive Supranuclear Palsy compared to Parkinson's Disease.
Sharma M; Mishra RK; Hall AJ; Casado J; Cole R; Nunes AS; Barchard G; Vaziri A; Pantelyat A; Wills AM
BMC Neurol; 2023 Dec; 23(1):434. PubMed ID: 38082255
[TBL] [Abstract][Full Text] [Related]
3. Acoustical analysis of speech in progressive supranuclear palsy.
Skodda S; Visser W; Schlegel U
J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
[TBL] [Abstract][Full Text] [Related]
4. Dysarthria enhancement mechanism under external clear speech instruction in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Skrabal D; Tykalova T; Klempir J; Ruzicka E; Rusz J
J Neural Transm (Vienna); 2020 Jun; 127(6):905-914. PubMed ID: 32193733
[TBL] [Abstract][Full Text] [Related]
5. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
Fiorenzato E; Weis L; Falup-Pecurariu C; Diaconu S; Siri C; Reali E; Pezzoli G; Bisiacchi P; Antonini A; Biundo R
J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
[TBL] [Abstract][Full Text] [Related]
6. Clinical speech impairment in Parkinson's disease, progressive supranuclear palsy, and multiple system atrophy.
Sachin S; Shukla G; Goyal V; Singh S; Aggarwal V; ; Behari M
Neurol India; 2008; 56(2):122-6. PubMed ID: 18688134
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
Sankhla CS; Patil KB; Sawant N; Gupta S
Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.
Quattrone A; Bianco MG; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Tedeschi G; Tessitore A; Cilia R; Morelli M; Nigro S; Vescio B; Arcuri PP; De Micco R; Cirillo M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
Mov Disord; 2022 Jun; 37(6):1272-1281. PubMed ID: 35403258
[TBL] [Abstract][Full Text] [Related]
9. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
10. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
[TBL] [Abstract][Full Text] [Related]
11. Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning.
De Vos M; Prince J; Buchanan T; FitzGerald JJ; Antoniades CA
Gait Posture; 2020 Mar; 77():257-263. PubMed ID: 32078894
[TBL] [Abstract][Full Text] [Related]
12. Machine learning on brain MRI data for differential diagnosis of Parkinson's disease and Progressive Supranuclear Palsy.
Salvatore C; Cerasa A; Castiglioni I; Gallivanone F; Augimeri A; Lopez M; Arabia G; Morelli M; Gilardi MC; Quattrone A
J Neurosci Methods; 2014 Jan; 222():230-7. PubMed ID: 24286700
[TBL] [Abstract][Full Text] [Related]
13. Quantitative evaluation of oculomotor disturbances in progressive supranuclear palsy.
Pagonabarraga J; Horta-Barba A; Busteed L; Bejr-Kasem H; Illán-Gala I; Aracil-Bolaños I; Marín-Lahoz J; Pascual-Sedano B; Pérez J; Campolongo A; Izquierdo C; Martinez-Horta S; Sampedro F; Kulisevsky J
Parkinsonism Relat Disord; 2021 Apr; 85():63-68. PubMed ID: 33744691
[TBL] [Abstract][Full Text] [Related]
14. Smaller and Denser Speech Graphs in Nondemented Patients with Progressive Supranuclear Palsy.
Ma J; Zhang G; Sun X; Chan P; Ye Z
Behav Neurol; 2023; 2023():3771601. PubMed ID: 37790602
[TBL] [Abstract][Full Text] [Related]
15. Instability of syllable repetition in progressive supranuclear palsy.
Skodda S; Grönheit W; Schlegel U
J Neural Transm (Vienna); 2012 Apr; 119(4):457-62. PubMed ID: 22065210
[TBL] [Abstract][Full Text] [Related]
16. Magnetic Resonance Parkinsonism Index and midbrain to pons ratio: Which index better distinguishes Progressive Supranuclear Palsy patients with a low degree of diagnostic certainty from patients with Parkinson Disease?
Nigro S; Morelli M; Arabia G; Nisticò R; Novellino F; Salsone M; Rocca F; Quattrone A
Parkinsonism Relat Disord; 2017 Aug; 41():31-36. PubMed ID: 28487107
[TBL] [Abstract][Full Text] [Related]
17. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
[TBL] [Abstract][Full Text] [Related]
18. Midbrain area for differentiating Parkinson's disease from progressive supranuclear palsy.
Ghourchian S; Mousavi A; Zamani B; Shahidi G; Rohani M
Clin Neurol Neurosurg; 2019 Aug; 183():105383. PubMed ID: 31181432
[TBL] [Abstract][Full Text] [Related]
19. Connected speech in progressive supranuclear palsy: a possible role in differential diagnosis.
Del Prete E; Tommasini L; Mazzucchi S; Frosini D; Palermo G; Morganti R; Pagni C; Tognoni G; Bonuccelli U; Ceravolo R
Neurol Sci; 2021 Apr; 42(4):1483-1490. PubMed ID: 32851538
[TBL] [Abstract][Full Text] [Related]
20. Utility and accuracy of perceptual voice and speech distinctions in the diagnosis of Parkinson's disease, PSP and MSA-P.
Miller N; Nath U; Noble E; Burn D
Neurodegener Dis Manag; 2017 Jun; 7(3):191-203. PubMed ID: 28632098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
